HUTCHMED (China) (HCM) Accounts Payables (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Accounts Payables came in at $5.9 million in Q4 2025, up 7.04% year-on-year from $5.5 million in Q4 2024, and down 86.61% on a QoQ basis from $43.7 million in Q2 2025.
HUTCHMED (China) (HCM) Accounts Payables (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Accounts Payables data on file, last reported at $5.9 million in Q4 2025.
- On a quarterly basis, Accounts Payables rose 7.04% year-over-year to $5.9 million in Q4 2025; TTM through Dec 2025 was $5.9 million, a 7.04% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 7.43% from the prior year.
- Accounts Payables for Q4 2025 stood at $5.9 million, down from $43.7 million in the prior quarter.
- Over the last five years, Accounts Payables for HCM reached as high as $4.6 billion in Q4 2023 and fell as low as $5.3 million in Q4 2021.
- Historically, Accounts Payables has averaged $447.7 million across 5 years, with a median of $28.6 million in 2021.
- Across the five-year window, Accounts Payables soared 51038.93% in 2023 and sank 99.88% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $5.3 million in 2021, then soared by 71.98% to $9.1 million in 2022, then surged by 51038.93% to $4.6 billion in 2023, then sank by 99.88% to $5.5 million in 2024, then gained by 7.04% to $5.9 million in 2025.
- Per Business Quant data, the three most recent Accounts Payables figures were $5.9 million in Q4 2025, $43.7 million in Q2 2025, and $5.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 5.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.85 Mn |
| Jun 30, 2025 | 43.73 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Jun 30, 2024 | 43.40 Mn |
| Dec 31, 2023 | 4.65 Bn |
| Jun 30, 2023 | 54.58 Mn |
| Dec 31, 2022 | 9.09 Mn |
| Jun 30, 2022 | 51.01 Mn |
| Dec 31, 2021 | 5.29 Mn |
| Jun 30, 2021 | 28.51 Mn |
| Mar 31, 2021 | 28.64 Mn |
| Jun 30, 2020 | 25.87 Mn |
| Sep 30, 2019 | 23.03 Mn |
| Jun 30, 2019 | 26.15 Mn |
| Mar 31, 2019 | 30.76 Mn |
| Dec 31, 2018 | 25.63 Mn |
| Jun 30, 2018 | 19.31 Mn |
| Dec 31, 2017 | 24.37 Mn |
| Jun 30, 2017 | 27.26 Mn |
| Dec 31, 2016 | 35.54 Mn |